AXQ Capital LP Buys Shares of 11,800 Teladoc Health, Inc. (NYSE:TDOC)

AXQ Capital LP bought a new stake in Teladoc Health, Inc. (NYSE:TDOC – Get Rating) in the 4th quarter, according to its most recent disclosure with the SEC. The fund bought 11,800 shares of the health services provider’s stock, valued at approximately $279,000.

Several other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in shares of Teladoc Health by 0.6% in the 3rd quarter. Vanguard Group Inc. now owns 13,639,307 shares of the health services provider’s stock valued at $345,757,000 after buying an additional 78,859 shares during the period. State of Michigan Retirement System lifted its stake in Teladoc Health by 1.2% during the fourth quarter. State of Michigan Retirement System now owns 3,783,000 shares of the health services provider’s stock worth $89,468,000 after purchasing an additional 43,500 shares during the last quarter. Two Sigma Advisers LP lifted its stake in Teladoc Health by 46.6% during the third quarter. Two Sigma Advisers LP now owns 1,661,711 shares of the health services provider’s stock worth $42,124,000 after purchasing an additional 528,100 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Teladoc Health by 313.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,658,323 shares of the health services provider’s stock worth $39,220,000 after purchasing an additional 1,257,493 shares during the last quarter. Finally, First Trust Advisors LP lifted its stake in Teladoc Health by 0.8% during the fourth quarter. First Trust Advisors LP now owns 1,610,622 shares of the health services provider’s stock worth $38,094,000 after purchasing an additional 13,572 shares during the last quarter. 84.14% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Trading Down 2.0 %

Shares of TDOC stock opened at $22.88 on Friday. The business’s fifty day moving average price is $25.47 and its 200 day moving average price is $26.64. Teladoc Health, Inc. has a 1-year low of $21.60 and a 1-year high of $44.66. The company has a quick ratio of 3.25, a current ratio of 3.37 and a debt-to-equity ratio of 0.67.

Teladoc Health (NYSE:TDOC – Get Rating) last announced its quarterly earnings data on Wednesday, April 26th. The health services provider reported ($0.37) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.51) by $0.14. Teladoc Health had a negative return on equity of 5.81% and a negative net margin of 285.51%. The firm had revenue of $629.24 million for the quarter, compared to analyst estimates of $617.55 million. On average, sell-side analysts anticipate that Teladoc Health, Inc. will post -1.38 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Teladoc Health news, insider Vidya Raman-Tangella sold 15,372 shares of the business’s stock in a transaction on Tuesday, May 2nd. The stock was sold at an average price of $26.76, for a total transaction of $411,354.72. Following the sale, the insider now directly owns 25,620 shares in the company, valued at $685,591.20. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Teladoc Health news, insider Vidya Raman-Tangella sold 15,372 shares of the business’s stock in a transaction on Tuesday, May 2nd. The stock was sold at an average price of $26.76, for a total transaction of $411,354.72. Following the sale, the insider now directly owns 25,620 shares in the company, valued at $685,591.20. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Arnnon Geshuri sold 1,090 shares of the business’s stock in a transaction on Monday, February 27th. The stock was sold at an average price of $26.69, for a total value of $29,092.10. Following the sale, the insider now owns 73,227 shares in the company, valued at $1,954,428.63. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 58,423 shares of company stock worth $1,514,860. 1.63% of the stock is owned by corporate insiders.

Analyst Ratings Changes

TDOC has been the subject of several recent analyst reports. JPMorgan Chase & Co. decreased their target price on Teladoc Health from $35.00 to $33.00 and set a “neutral” rating for the company in a research note on Monday, February 27th. Barclays lifted their price target on Teladoc Health from $28.00 to $29.00 in a research report on Thursday, April 27th. 58.com reaffirmed a “maintains” rating on shares of Teladoc Health in a research report on Thursday, April 27th. Citigroup cut their price target on Teladoc Health from $33.00 to $30.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 28th. Finally, Wells Fargo & Company cut their price target on Teladoc Health from $28.00 to $23.00 and set an “equal weight” rating on the stock in a research report on Monday, March 6th. One investment analyst has rated the stock with a sell rating, seventeen have issued a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $32.78.

About Teladoc Health

(Get Rating)

Teladoc Health, Inc engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services.